Analysis of Montelukast Sodium Using Prominence-i and Nexera-i MT

LAAN-A-LC-E295 Application News No. L520 High Performance Liquid Chromatography Analysis of Montelukast Sodium Using Prominence-i and Nexera-i MT Montelukast sodium is used as a therapeutic drug for treating bronchial asthma and allergic rhinitis, and is listed in the 17th edition…

C10G-E056 Solutions for Pharmaceutical Analysis Application Notebook First Edition: March, 2018 © Shimadzu Corporation, 2018 Solutions for Pharmaceutical Analysis Index Application Notebook Basic Research and Drug Discovery Development of a Phospholipid Profiling Method Using Triple Quadrupole LC-MS/MS This article shows…

C196-E091B LC Systems Nexera-i Prominence-i -Series Plus intuitive Achieving Easier Operation innovative Advanced Interactive Design intelligent Smart Features Increase Work Efficiency Shimadzu's integrated LC system has been reborn as i-Series Plus. Equipped with ACTO technology for even smoother migration of…

LAAN-A-LC-E323 Application News No. High Performance Liquid Chromatography Analysis of Meloxicam in Accordance with the United States Pharmacopoeia by NexeraTM XR L550 mAU 220 Meloxicam, inhibits the biosynthesis of prostaglandin, is utilized as an anti-inflammatory and analgesic for arthritis. In…